Viewing Study NCT04803227


Ignite Creation Date: 2026-03-26 @ 3:21 PM
Ignite Modification Date: 2026-04-14 @ 7:32 PM
Study NCT ID: NCT04803227
Status: TERMINATED
Last Update Posted: 2022-01-04
First Post: 2021-02-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19
Sponsor: Histogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module